Andrew Shales

Vorstandsvorsitzender bei

Key Positioning Ltd.

64 Jahre

20 Beziehungen

Health Technology

Communications

Consumer Services

Profil

Andrew D.
Shales is currently the Chief Executive Officer at Key Positioning Ltd. and Resilia Pharmaceuticals, Inc. He previously served as the Chief Operating Officer & Secretary at Multi-Link Telecommunications, Inc. and as the Chief Operating Officer at Auriga Laboratories, Inc. He also held the position of Chief Operating Officer & Secretary at Auriga Laboratories, Inc. from 2006 to 2007.
Shales received his undergraduate degree from King's College (Pennsylvania) in 1986.

Aktive Positionen von Andrew Shales

Unternehmen	Position	Beginn
Key Positioning Ltd.	Vorstandsvorsitzender	-
Resilia Pharmaceuticals , Inc. Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales.	Vorstandsvorsitzender	-

Alle aktiven Positionen von Andrew Shales

Ehemalige bekannte Positionen von Andrew Shales

Unternehmen	Position	Ende
Auriga Laboratories, Inc. Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products	Geschäftsführer	05.11.2007
Multi-Link Telecommunications, Inc. Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses	Geschäftsführer	21.07.2006
Auriga Laboratories, Inc. /Old/ Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products	Geschäftsführer	20.07.2006

Sehen Sie sich die Erfahrung von Andrew Shales im Detail an

Ausbildung von Andrew Shales

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Andrew Shales im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	6
Multi-Link Telecommunications, Inc. Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses	Communications
Auriga Laboratories, Inc. /Old/ Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products	Health Technology
King's College (Pennsylvania) King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Auriga Laboratories, Inc. Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products	Health Technology
Key Positioning Ltd.
Resilia Pharmaceuticals , Inc. Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales.	Health Technology